Hans Minderman

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells

S. Olejniczak, W. Storkus, N. Obermajer, 2023, Research square.

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

M. Opyrchal, O. Maguire, Kathleen M Kokolus, 2023, Journal for ImmunoTherapy of Cancer.

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.

P. Westervelt, A. Alousi, R. Maziarz, 2023, Bone marrow transplantation.